Asenapine Maleate API Market Size, Share, Trends, Growth and Forecast 2034

Asenapine Maleate API Industry Prospective:

The global asenapine maleate API market size was worth around USD 855.79 million in 2024 and is predicted to grow to around USD 1,655.36 million by 2034, with a compound annual growth rate (CAGR) of roughly 6.82% between 2025 and 2034.

Request Free Sample

Asenapine Maleate API Market: Overview

Asenapine maleate active pharmaceutical ingredient (API) is the raw material used to produce asenapine. The industry deals with the procurement and application of maleate, a saleable form of API used for producing asenapine, which is an atypical antipsychotic drug.

According to industry research, asenapine is used widely across the globe for the treatment of mental health conditions in the form of bipolar I disorder and schizophrenia.

Asenapine belongs to the dibenzo-oxepino pyrrole class and is also popular as an effective drug in treating severe post-traumatic stress disorder nightmares, especially among military professionals. The maleic salt form of the raw material is known to improve the bioavailability, solubility, and overall stability of the final drug. During the forecast period, the industry for asenapine maleate API is expected to grow due to the rising demand for asenapine.

In addition to this, the surge in the number of patients with mental health disorders, along with increased investments in the pharmaceutical and biotechnology industries, will propel the market demand rate.

The industry players can expect certain growth barriers due to disruptions in the supply chain of critical resources and end products. Additionally, complexities with regulatory approvals may further affect final revenue in the industry.

Key Insights:

• As per the analysis shared by our research analyst, the global asenapine maleate API market is estimated to grow annually at a CAGR of around 6.82% over the forecast period (2025-2034)
• In terms of revenue, the global asenapine maleate API market size was valued at around USD 855.79 million in 2024 and is projected to reach USD 1,655.36 million by 2034.
• The asenapine maleate API market is projected to grow at a significant rate due to the growing number of patients with mental health conditions.
• Based on the application, the pharmaceutical formulation segment is growing at a high rate and will continue to dominate the global market as per industry projections.
• Based on the end-user, the contract manufacturing organizations (CMOs) segment is anticipated to command the largest market share.
• Based on region, Asia-Pacific is projected to dominate the global market during the forecast period.

Asenapine Maleate API Market: Growth Drivers

Growing number of patients with mental health conditions to propel market demand rate

The global asenapine maleate API market is expected to be driven by the rising number of patients suffering from mental health conditions. Asenapine maleate API is used to produce Saphris, also known as asenapine. It is a critical drug used for treating conditions such as bipolar disorder and schizophrenia. The tablet quickly dissolves under the tongue and hence can be easily ingested by mental health patients.

Asenapine is characterized by second-generation (atypical) antipsychotics. It works by creating a balance between dopamine and serotonin, which are essential brain chemicals.

In recent times, the official number of patients suffering from critical mental conditions has increased. The increased diagnosis rate is associated with the growing acceptance of mental health conditions as genuine medical problems. The general population has become desensitized toward disorders such as schizophrenia and bipolar conditions due to repeated exposure to awareness programs regarding such medical conditions.

Furthermore, growing access to diagnostic centers and effective medications worldwide has also benefited the industry for asenapine maleate API.

Increasing international and domestic strategic partnerships between key stakeholders to open new avenues for growth

The mounting pressure on the global healthcare sector has forged increased strategic partnerships between key stakeholders in the market. The surging rate of collaboration between research companies, pharmaceutical institutions, government entities, and contract manufacturing organizations (CMOs) on a global scale is expected to create new growth avenues for the global asenapine maleate API industry players.

Asenapine Maleate API Market: Restraints

Supply chain disruptions are expected to impact overall revenue in the industry

The global industry for asenapine maleate API is projected to be restricted due to ongoing concerns over supply chain disruption of essential raw materials or final goods.

The production of Asenapine Maleate API required the use of maleic acid, 5-chloro-2-methylbenzene derivatives, pyrrole, methanol/ethanol, magnesium, and other crucial chemicals.

However, ongoing changes in geopolitical conditions worldwide may impact the timely and sufficient availability of the substances, impacting overall market revenue.

Asenapine Maleate API Market: Opportunities

Increasing investments in the pharmaceutical industry and healthcare sector to generate growth opportunities

The global asenapine maleate API market is projected to generate growth opportunities due to the increasing investments in the pharmaceutical sector worldwide.

The exponentially growing number of patients worldwide against the backdrop of deteriorating quality of life, increasing accidents, rising geriatric population, and other factors has burdened the existing health sector. This, in turn, is encouraging more investments in the global pharmaceutical sector to meet the healthcare needs of the general population.

In April 2025, reports emerged suggesting that BDR Pharmaceuticals, a leading drugmaker from the Indian market, is expected to invest nearly USD 100 million, aiming to expand in the US market.

Furthermore, regional governments are offering renewed subsidies, performance-linked incentive (PLI) schemes, and improved infrastructure to promote foreign investments and encourage domestic drug makers.

In 2024, Africa’s Transform Health Fund (THF), a strategic initiative to improve funds in Africa’s healthcare sector, announced closure with a total investment of USD 111 million.

Asenapine Maleate API Market: Challenges

Changing government regulations and production complexities to challenge market expansion

The global asenapine maleate API industry is projected to be challenged by the presence of a complex and dynamic government regulatory environment.

The production and end-user of asenapine maleate API or the final drug is subject to changes in government regulations. Asenapine is associated with several side effects such as dizziness, restlessness, problems with movement, tingling in the mouth, increased appetite, and others.

Furthermore, complexities associated with the production of asenapine maleate API due to the intensity of the production process may impact final revenue in the industry.

Asenapine Maleate API Market: Report Scope

Asenapine Maleate API Market: Segmentation

The global asenapine maleate API market is segmented based on application, end-user, and region.

Based on the application, the global market segments are research & development and pharmaceutical formulation. In 2024, the highest revenue was listed in the pharmaceutical formulation segment, led by the effective use of the raw material in the production of Saphris. The rising number of patients worldwide with mental health disorders is fueling the segmental revenue, according to analysis. According to the National Institute of Mental Health (NIMH), more than 2.8% of the US adult population was diagnosed with bipolar disorder in 2024.

Based on the end-user, the global market divisions are contract manufacturing organizations (CMOs), research institutes, and pharmaceutical companies. In 2024, the CMOs segment was the largest revenue generator. Contract manufacturing organizations offer scalable production capacity, expertise, and access to advanced production equipment, assisting pharmaceutical companies in achieving drug production targets. In 2024, the global CMO industry was valued at over USD 200 billion, according to industry experts.

Asenapine Maleate API Market: Regional Analysis

Asia-Pacific to deliver exceptional results during the forecast period

The global asenapine maleate API market will be led by Asia-Pacific during the forecast period. According to industry research, China and India will emerge as the top contributors to the regional economy.

Growth in Asia-Pacific is influenced by the presence of an exceptionally well-growing and prominent pharmaceutical industry. Some of these companies are Takeda Pharmaceutical Company Limited, Sun Pharmaceutical Industries Ltd., Fresenius Kabi Asia Pacific, and Eisai Co., Ltd., among several others. Asia-Pacific has access to robust drug manufacturing facilities and has produced mechanisms to achieve cost-efficiency.

North America is expected to be led by the US during the projection period. The rising number of patients with schizophrenia and bipolar disorders has helped the regional market thrive in the last few years.

Social acceptance of mental health conditions in North America has improved, driven by an increase in public awareness programs and better access to forums where patients can confidently discuss their health issues.

Furthermore, the regional healthcare sector is one of the prominent industries with an exceptional rate of access to basic healthcare among the general population.

Asenapine Maleate API Market: Competitive Analysis

The global asenapine maleate API market is led by players like:

• MSN Laboratories
• CHEMO
• Dr. Reddy's Laboratories
• Alembic Pharmaceuticals Limited
• Haoyuan Chemexpress Co. Ltd
• Medichem S.A
• Zhejiang Ausun Pharmaceutical
• Globofarm International
• Inke S.A.
• LGM Pharma
• Megafine Pharma (P) Limited
• Shouyuan Chemical
• Acura Labs
• Viatris
• Olon S.p.A.

The global asenapine maleate API market is segmented as follows:

By Application

• Research & Development
• Pharmaceutical Formulations

By End-User

• Contract Manufacturing Organizations (CMOs)
• Research Institutes
• Pharmaceutical Companies

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France 
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa